Q4/2023 12/31/2023 EPS -0.110 ZacksConsensus -0.090 ActVsEst (0.020) - Miss
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Wall Street Horizon
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- Ginkgo Bioworks eligible for $9.4M in partnership for bioelectronic devices [Seeking Alpha]Seeking Alpha
- Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT ProgramPR Newswire
- Upstream Bio Appoints Allison Ambrose as General Counsel [Yahoo! Finance]Yahoo! Finance
- Industrial Biomanufacturing Market Report 2025-2035, with Profiles of 1,100+ Companies Active in the Industrial Biomanufacturing Space [Yahoo! Finance]Yahoo! Finance
DNA
Earnings
- 11/12/24 - Beat
DNA
Sec Filings
- 12/26/24 - Form 144
- 12/26/24 - Form 144
- 12/23/24 - Form 144
- DNA's page on the SEC website